China poses increasing security risk as US biotech innovation edge erodes

◆ ◆ The Wire takeaway

You need to prepare for tighter U.S. government scrutiny and potential shifts in biotech funding and regulation as national security concerns drive a push to resecure innovation leadership from China. Your ability to navigate rising geopolitical risk will be critical to maintaining market access and funding.